BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.73 Cr | ₹1.55 Cr | ₹1.51 Cr | ₹1.77 Cr | ₹1.59 Cr |
What is the latest Contingent Liabilities ratio of BETA DRUGS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.73 Cr |
| Mar2024 | ₹1.55 Cr |
| Mar2023 | ₹1.51 Cr |
| Mar2022 | ₹1.77 Cr |
| Mar2021 | ₹1.59 Cr |
How is Contingent Liabilities of BETA DRUGS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.73 Cr | 11.84 | |
| Mar2024 | ₹1.55 Cr | 2.38 | |
| Mar2023 | ₹1.51 Cr | -14.74 | |
| Mar2022 | ₹1.77 Cr | 11.17 | |
| Mar2021 | ₹1.59 Cr | - | |
Compare Contingent Liabilities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,224.4 Cr | -1.8% | -6.2% | 14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -1.8% |
-6.2% |
14.4% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses